Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast …

WB Fang, M Medrano, P Cote, M Portsche… - Frontiers in …, 2023 - frontiersin.org
Background/Introduction As the most common form of pre-invasive breast cancer, ductal
carcinoma in situ (DCIS) affects over 50,000 women in the US annually. Despite …

Genomic landscape of ductal carcinoma in situ and association with progression

CY Lin, S Vennam, N Purington, E Lin, S Varma… - Breast cancer research …, 2019 - Springer
Purpose The detection rate of breast ductal carcinoma in situ (DCIS) has increased
significantly, raising the concern that DCIS is overdiagnosed and overtreated. Therefore …

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

SH Strand, B Rivero-Gutiérrez, KE Houlahan… - Cancer cell, 2022 - cell.com
Ductal carcinoma in situ (DCIS) is the most common precursor of invasive breast cancer
(IBC), with variable propensity for progression. We perform multiscale, integrated molecular …

Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal …

S Schultz, H Bartsch, K Sotlar, K Petat-Dutter… - BMC medical …, 2018 - Springer
Background The transition from ductal carcinoma in situ (DCIS) to invasive breast carcinoma
(IBC) is an important step during breast carcinogenesis. Understanding its molecular …

[HTML][HTML] Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer

EV Elias, NP De Castro, PHB Pineda, CS Abuázar… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Breast cancer biomarkers that can precisely predict the risk of progression of non-invasive
ductal carcinoma in situ (DCIS) lesions to invasive disease are lacking. The identification of …

Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ

M Tokura, J Nakayama, M Prieto-Vila, S Shiino… - Cancer Research, 2022 - AACR
Ductal carcinoma in situ (DCIS) is a precursor to invasive breast cancer. The frequency of
DCIS is increasing because of routine mammography; however, the biological features and …

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

AK Casasent, MM Almekinders, C Mulder… - Nature Reviews …, 2022 - nature.com
Ductal carcinoma in situ (DCIS) is a non-invasive breast neoplasia that accounts for 25% of
all screen-detected breast cancers diagnosed annually. Neoplastic cells in DCIS are …

ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness

Y Liu, PR Pandey, S Sharma, F Xing, K Wu… - Breast cancer research …, 2019 - Springer
Purpose Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer which could
progress to or recur as invasive breast cancer. The underlying molecular mechanism of …

Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia

ES Knudsen, A Ertel, E Davicioni, J Kline… - Breast cancer research …, 2012 - Springer
Ductal carcinoma in situ (DCIS) is a precursor lesion that can gives rise to invasive breast
cancer (IBC). It has been proposed that both the nature of the lesion and the tumor …

Human ductal carcinoma in situ: advances and future perspectives

F Behbod, JH Chen… - Cold Spring …, 2023 - perspectivesinmedicine.cshlp.org
Due to widespread adoption of screening mammography, there has been a significant
increase in new diagnoses of ductal carcinoma in situ (DCIS). However, DCIS outcomes …